ATE297726T1 - Forskolin zur entwicklung magerer körpermasse - Google Patents

Forskolin zur entwicklung magerer körpermasse

Info

Publication number
ATE297726T1
ATE297726T1 AT98907537T AT98907537T ATE297726T1 AT E297726 T1 ATE297726 T1 AT E297726T1 AT 98907537 T AT98907537 T AT 98907537T AT 98907537 T AT98907537 T AT 98907537T AT E297726 T1 ATE297726 T1 AT E297726T1
Authority
AT
Austria
Prior art keywords
forskohlin
body mass
lean body
disclosed
treating
Prior art date
Application number
AT98907537T
Other languages
English (en)
Inventor
Muhammed Majeed
Vladimir Badmaev
Ramaswamy Rajendran
Original Assignee
Sabinsa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25196877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE297726(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sabinsa Corp filed Critical Sabinsa Corp
Application granted granted Critical
Publication of ATE297726T1 publication Critical patent/ATE297726T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pyrane Compounds (AREA)
AT98907537T 1997-02-27 1998-02-26 Forskolin zur entwicklung magerer körpermasse ATE297726T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/807,652 US5804596A (en) 1997-02-27 1997-02-27 Method of preparing a forskohlin composition from forskohlin extract and use of forskohlin for promoting lean body mass and treating mood disorders
PCT/US1998/003268 WO1998037883A1 (en) 1997-02-27 1998-02-26 Forskohlin for promoting lean body mass

Publications (1)

Publication Number Publication Date
ATE297726T1 true ATE297726T1 (de) 2005-07-15

Family

ID=25196877

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98907537T ATE297726T1 (de) 1997-02-27 1998-02-26 Forskolin zur entwicklung magerer körpermasse

Country Status (11)

Country Link
US (1) US5804596A (de)
EP (1) EP0977564B1 (de)
JP (1) JP2001508801A (de)
AT (1) ATE297726T1 (de)
AU (1) AU6331898A (de)
CA (1) CA2281562C (de)
DE (1) DE69830578T2 (de)
DK (1) DK0977564T3 (de)
ES (1) ES2241121T3 (de)
PT (1) PT977564E (de)
WO (1) WO1998037883A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6426096B1 (en) * 1997-12-10 2002-07-30 Paolina Galvao Anorexigenic composition
US6696495B2 (en) * 1998-12-02 2004-02-24 Snowden Pharmaceuticals, Llc Treatment of disorders secondary to organic impairments
US6323242B1 (en) 1998-12-02 2001-11-27 Peter Sterling Mueller Treatment of disorders secondary to organic impairments
US20020119933A1 (en) * 2000-07-28 2002-08-29 Butler Terri L. Compositions and methods for improving cardiovascular function
US6429198B1 (en) 1999-04-12 2002-08-06 Bioenergy Inc. Compositions for increasing athletic performance in mammals
AU2002258391A1 (en) * 2001-02-20 2002-09-19 Sabinsa Corporation Essential oil from.coleus forskohlii, production process and use as antimicrobial agent
EP1277412A1 (de) * 2001-07-17 2003-01-22 Societe Des Produits Nestle S.A. Haustierfutterzusammensetzung zur Regulierung des Körpergewichts und zur Verhinderung der Fettleibigkeit und ähnlicher Störungen bei Haustieren
US6855358B1 (en) * 2002-11-01 2005-02-15 Enhanced Beverages, Llc Process for addition of a nutraceutical to a beverage
US7202222B2 (en) * 2003-01-06 2007-04-10 National Bioscience Corporation Methods for treatment of obesity and effective fat loss promotion
US6913769B2 (en) 2003-02-18 2005-07-05 Brian Douglas Oslick Compositions for prevention and treatment of symptoms associated with ethyl alcohol consumption
US20050025844A1 (en) * 2003-08-02 2005-02-03 Matthias Boldt Weight control compositions and methods
US6960300B2 (en) * 2003-09-08 2005-11-01 Sami Labs Limited Process for preparing water soluble diterpenes and their applications
US20060122261A1 (en) * 2003-11-20 2006-06-08 Muhammed Majeed [method of preparing labdane diterpene composition, preferably isoforskolin and deacetylforskolin from forskolin extract and their use for promoting lean body mass and other applications]
PL209905B1 (pl) 2004-01-15 2011-11-30 Bringwell Internat Ab Preparat do leczenia otyłości i związanego z nią syndromu metabolicznego
JP3790767B2 (ja) 2004-06-30 2006-06-28 森下仁丹株式会社 脂肪代謝改善組成物
US20060004090A1 (en) * 2004-07-01 2006-01-05 Roberts William J Forskolin compositions and methods for administration
US20110077292A1 (en) * 2004-07-01 2011-03-31 Biotest Laboratories, Llc. Forskolin carbonates and uses thereof
US20060134230A1 (en) * 2004-12-17 2006-06-22 Sal Abraham Weight loss composition and formulation
US7588759B2 (en) * 2004-12-17 2009-09-15 Avoca, Inc. Compositions comprising sclareol or derivatives thereof and uses thereof
US20080075792A1 (en) * 2006-09-21 2008-03-27 Naturalendo Tech Co., Ltd. Method for inhibiting the activity of DPP-IV and lowering blood glucose level
JP2010516731A (ja) * 2007-01-24 2010-05-20 グラクソ グループ リミテッド ２−メトキシ−５−（５−トリフルオロメチル−テトラゾール−１−イル）−ベンジル］−（２ｓ−フェニル−ピペリジン−３ｓ−イル）−アミンを含む医薬組成物
US8062679B2 (en) * 2007-05-10 2011-11-22 Northern Innovations And Formulations Corp. Composition for maintaining androgen and androgen-like uptake potential by cells
US20090098220A1 (en) * 2007-10-12 2009-04-16 Lance Ashworth Liquid pharmaceutical preparation comprising forskolin for promoting lean body mass
US20090126048A1 (en) * 2007-11-08 2009-05-14 Ven Subbiah Method For Growing Forskohlin Containing Coleus In A Temperate Climate
US8968804B2 (en) 2012-08-23 2015-03-03 Nestec Sa Methods for managing weight loss and body mass
US9283196B1 (en) 2013-01-30 2016-03-15 MediSynergics, LLC Cycloalkyl-diamines for CNS disorders
WO2017136143A1 (en) 2016-02-01 2017-08-10 Ribocor, Inc. Use of ribose for treatment of subjects having congestive heart failure
CN107302997A (zh) * 2016-04-19 2017-10-31 林秀霞 一种抑制脂肪蓄积的组合物及其用途
US12350251B2 (en) * 2016-11-21 2025-07-08 Rev Pharmaceuticals, Inc. Sexual health enhancement composition
JP7216711B2 (ja) 2017-09-12 2023-02-01 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 長期的なカロリー制限を再現し、動物に健康上の利益を与えるための方法
DE202017006287U1 (de) 2017-12-05 2018-03-02 Freia Hünig Medikament zur extern läsionalen und intraläsionalen Therapie des Basalioms
DE202017006288U1 (de) 2017-12-05 2018-01-17 Freia Hünig Kosmetisches Mittel zur Verkleinerung von Hautporen
MX2020007179A (es) 2017-12-21 2020-08-24 Nestle Sa Sistemas para controlar la perdida de peso y la masa corporal.
DE202018000088U1 (de) 2018-01-08 2018-01-29 Freia Hünig Kosmetisches Mittel zur Volumensteigerung der Lippen und Intensivierung des Lippenrots
DE202018000087U1 (de) 2018-01-08 2018-01-23 Freia Hünig Kosmetisches Mittel zur Hautverjüngung
WO2019212929A1 (en) * 2018-04-30 2019-11-07 Muhammed Majeed Compositions for weight loss

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4476140A (en) * 1983-05-16 1984-10-09 Yale University Composition and method for treatment of glaucoma
DE3815718A1 (de) * 1988-05-07 1989-11-16 Hoechst Ag Mittel zur wachstumssteigerung bei tieren
JPH06133731A (ja) * 1992-10-23 1994-05-17 Zenetsukusu Kk ダイエット食品

Also Published As

Publication number Publication date
PT977564E (pt) 2005-08-31
DK0977564T3 (da) 2005-10-17
EP0977564A4 (de) 2002-11-27
AU6331898A (en) 1998-09-18
US5804596A (en) 1998-09-08
CA2281562C (en) 2008-06-17
DE69830578T2 (de) 2005-10-06
JP2001508801A (ja) 2001-07-03
CA2281562A1 (en) 1998-09-03
EP0977564A1 (de) 2000-02-09
EP0977564B1 (de) 2005-06-15
DE69830578D1 (de) 2005-07-21
ES2241121T3 (es) 2005-10-16
WO1998037883A1 (en) 1998-09-03

Similar Documents

Publication Publication Date Title
DE69830578D1 (de) Forskolin zur entwicklung magerer körpermasse
ATE256475T1 (de) Verwendung von follistatin zur herstellung eines arzneimittels zur behandlung von muskuläre krankheiten
LV10192A (lv) Farmaceitisks pretaptaukosanas sastavs
ATE73331T1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
KR880700668A (ko) 특정 생체조직 부위로의 전달을 위한 아미노산 킬레이트의 조성물
AR052921A1 (es) Uso de ranolazina para la preparacion de una composicion farmaceutica y composicion farmaceutica
DE69636343D1 (de) Verwendung von glu-trp dipeptiden zur herstellung eines arzneimittels zur behandlung von verschiedenen gefässneubildung-assozierten erkrankungen
BG103740A (en) Phytostyrene composition for the prevention of the alzheimer's disease
ATE93143T1 (de) Verwendung eines lysozymdimeren und/oder ribonucleasedimeren zur herstellung eines antiviralen oder antibakteriellen arzneimittels.
EP0831882A4 (de) Zusammensetzungen aus rekonstituierten kollagenfasersegmenten und verfahren zu ihrer herstellung
ATE110265T1 (de) Verwendung von sigma-rezeptor-liganden zur herstellung eines anxiolytikums.
ZA953358B (en) New pharmaceutical composition based on taxoids
TR200103634T2 (tr) Bitkilerde flavonoidlerin ve fenolik maddelerin miktarını arttırma yöntemi.
DE69122364D1 (de) Verwendung von (S)-Isofluran und (S)-Desfluran zur Anästhesie sowie entsprechende Arzneimittelzubereitungen
DE69327004D1 (de) Pharmazeutische formulierungen mit kontrollierter freigabe von 3'-azido-3'-deoxythymidin und verfahren zur verwendung
ATE307203T1 (de) Verwendung eines anti-interleukin-9 antikörpers zur herstellung eines medikamentes zur behandlung von asthma
ATE107168T1 (de) Verwendung von gepiron zur herstellung eines pharmazeutischen präparats zur behandlung atypischer depression.
ES2012128A6 (es) Metodo de tratar plantas con acidos organicos que contienen azufre.
DE3676640D1 (de) Prazosin-pirbuterol-mischung zur bronchendilatation.
ATE190628T1 (de) Zusammensetzungen von wachstumsfaktoren, herstellung und verwendung
BR9810884A (pt) Uso de uma preparação de lipìdeo derivada de uma fonte natural enriquecida
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin
ATE200425T1 (de) Verfahren zur extraktion und verwendung von muira puama
KR910004603A (ko) 신규 화합물
MD1135F1 (en) Paradontium treatment method

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0977564

Country of ref document: EP